SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Encrantz Staffan

(Last)

(First)

(Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE, SUITE 100

(Street)

MENLO PARK

94025

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/14/2021

3. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Redeemable Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	1,449,274	⁽¹⁾	I	See footnote⁽²⁾
Series B Redeemable Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	197,490	⁽¹⁾	I	See footnote⁽²⁾
Series C Redeemable Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	1,323,306	⁽¹⁾	I	See footnote⁽²⁾
Series C Redeemable Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	632,456	⁽¹⁾	I	See footnote⁽³⁾

Explanation of Responses:

1. The preferred stock is convertible into common stock on a 2 for 1 basis and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.

2. These shares are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President and owner of Allegro Investment Inc., the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund. The Reporting Person disclaims beneficial ownership of the shares held by Allegro Investment Fund (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose), except to the extent of his pecuniary interest therein, if any.

3. These shares are held of record by Allegro Investors LLC ("Allegro Investors"). The Reporting Person is a member of Allegro Investors and may be deemed to beneficially own the shares held by Allegro Investors.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Jeremy Hayden, Attorney-in-Fact for Staffan Encrantz	07/14/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.